With less than five years remaining to achieve the United Nations Sustainable Development Goals, South Africa faces a critical challenge: ending the tuberculosis (TB) epidemic. The goal is ambitious: an 80% reduction in TB incidence and a 90% decline in TB deaths...
South African HIV/AIDS researchers are grappling with the harsh reality of substantial grant funding cuts from the US National Institutes of Health (NIH). These cuts, resulting from a shift in NIH priorities, threaten to derail decades of progress in combating...
The US Food and Drug Administration (FDA) has raised serious concerns regarding the manufacturing standards of eye drops produced by Aspen Pharmacare at its sterile facility in Gqeberha, South Africa. In a warning letter, the FDA highlighted potential risks of...
Health Minister Aaron Motsoaledi has reassured Parliament that he is confident in achieving its ambitious HIV treatment targets despite recent cuts in US aid. The minister’s assurance comes as a response to concerns raised by MPs regarding the potential impact...
Pharmaceutical giants are actively lobbying the Trump administration and European Union officials to exclude medical goods from escalating trade disputes. They fear significant price increases and restricted patient access to essential medications. The...